Issued Patents All Time
Showing 25 most recent of 26 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10071108 | Methods and pharmaceutical compositions for the treatment of hepatitis b virus infection | Patrice Andre, Vincent Lotteau, Pauline Radreau, Marine Gilardone, Amaury Patin +2 more | 2018-09-11 |
| 9895380 | Methods and pharmaceutical compositions for the treatment of hepatitis B virus infection | Patrice Andre, Vincent Lotteau, Pauline Radreau, Marine Gilardone, Amaury Patin +2 more | 2018-02-20 |
| 9365584 | Thieno [2,3-B] pyridinedione activators of AMPK and therapeutic uses thereof | Sophie Hallakou-Bozec, Sébastien Bolze, Franck Lepifre, Laurent Faveriel, Jean-Denis Durand +1 more | 2016-06-14 |
| 9284329 | Thienopyridone derivatives useful as activators of AMPK | Sophie Hallakou-Bozec, Sébastien Bolze, Franck Lepifre, Laurent Faveriel, Jean-Denis Durand +1 more | 2016-03-15 |
| 9271984 | Treatment of type 1 diabetes | Pascale Fouqueray, Sophie Hallakou-Bozec, Sébastien Bolze | 2016-03-01 |
| 9035048 | Tetrahydrotriazine compounds for treating diseases associated with AMPK activity | Sophie Hallakou-Bozec, Didier Mesangeau, Samer Elbawab | 2015-05-19 |
| 8980828 | Combination of insulin with triazine derivatives and its use for treating diabetes | Didier Mesangeau, Annick Audet | 2015-03-17 |
| 8937066 | Amino derivatives of dihydro-1,3,5-triazine used in the treatment of ischemia and/or reperfusion related diseases | Didier Mesangeau, Xavier Leverve | 2015-01-20 |
| 8791115 | Combination of triazine derivatives and insulin sensitisers | Gerard Moinet, Didier Mesangeau | 2014-07-29 |
| 8742102 | Process for enantiomeric separation of racemic dihydro-1,3,5 triazines via preferential crystallization | Matthias Helmreich, Claus-Peter Niesert, Gerard Coquerel, Guillaume Levilain, Saoussen Wacharine-Antar +1 more | 2014-06-03 |
| 8742103 | Separation of triazine derivatives enantiomers using tartaric acid | Matthias Helmreich | 2014-06-03 |
| 8674097 | Quinoxalinedione derivatives useful as activators of AMPK-activated protein kinase | Sophie Hallakou-Bozec, Franck Lepifre | 2014-03-18 |
| 8604202 | Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activators | Franck Lepifre, Sophie Hallakou-Bozec, Christine Charon | 2013-12-10 |
| 8592370 | Combination of insulin with triazine derivatives | Didier Mesangeau, Annick Audet | 2013-11-26 |
| 8563729 | Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activators | Franck Lepifre, Sophie Hallakou-Bozec, Christine Charon | 2013-10-22 |
| 8420642 | Pyridine derivatives useful as glucokinase activators | Lars Burgdorf, Norbert Beier, Johannes Gleitz, Christine Charon | 2013-04-16 |
| 8329698 | Quinoxalinedione derivatives which are activators of AMPK-activated protein kinase | Sophie Hallakou-Bozec, Franck Lepifre | 2012-12-11 |
| 8227465 | Combination of triazine derivatives and insulin secretion stimulators | Gerard Moinet, Didier Mesangeau | 2012-07-24 |
| 8217040 | Use of triazine derivatives for the manufacture of a medicament having a cicatrising or angiogenic effect | Gerard Moinet | 2012-07-10 |
| 7767676 | Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses | Gerard Moinet, Liliane Doare, Micheline Kergoat, Didier Mesangeau | 2010-08-03 |
| 7501511 | Process for resolving aimines that are useful for the treatment of disorders associated with insulin resistance syndrome | Gerard Moinet, Thierry Passemar | 2009-03-10 |
| 7491733 | Bicyclic guanidine derivatives and therapeutic uses thereof | Gerard Moinet | 2009-02-17 |
| 7452883 | Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses | Gerard Moinet, Liliane Doare, Micheline Kergoat, Didier Mesangeau | 2008-11-18 |
| 7285681 | Biguanide derivatives | Gerard Moinet | 2007-10-23 |
| 7034021 | Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses | Gerard Moinet, Liliane Doare, Micheline Kergoat, Didier Mesangeau | 2006-04-25 |